Earnings Call Transcripts
Access detailed transcripts and key takeaways from company earnings calls
All Earnings Calls
South Bow Q4 2025 Earnings Call - Blackrod Online as Keystone Remediation Holds Near-Term Capacity, Prairie Connector Signals Growth
South Bow closed 2025 with a modest beat and a message of control. Normalized EBITDA came in at $1.02 billion, distributable cash flow was $709 million, and net debt to normalized EBITDA tightened to ...
- South Bow slightly beat 2025 expectations, reporting normalized EBITDA of $1.02 billion versus guidance of $1.01 billion.
- Distributable cash flow for 2025 was $709 million, over 30% above the company’s original guidance.
- Net debt to normalized EBITDA improved to 4.7 times at year-end 2025, modestly better than the 4.8 times expected.
- +12 more takeaways
Loma Negra Fourth Quarter 2025 Earnings Call - Recovery Loses Momentum, Margins Under Pressure
Loma Negra closed 2025 in a slow-healing market. Q4 cement dispatches fell 1.2% year-over-year, revenues slipped 1.7% to ARS 225 billion (USD 152 million), and adjusted EBITDA for the quarter was USD ...
- Q4 cement dispatches declined 1.2% year-over-year, mirroring a slower-than-expected recovery in the second half of 2025.
- Q4 revenues were ARS 225 billion (USD 152 million), down 1.7% year-over-year; full year 2025 revenues fell 7.8% to ARS 848 billion.
- Adjusted EBITDA for Q4 was USD 37 million (ARS 44 billion) with a 19.7% margin, down about 938 basis points year-over-year from an unusually strong prior-year base.
- +12 more takeaways
BCP Investment Corporation Q4 2025 Earnings Call - Debt Refinanced and Buybacks Accretive, NAV Still Under Pressure
2025 was a year of heavy housekeeping for BCP Investment Corporation. Management closed the Logan Ridge merger, rebranded under the BC Partners credit umbrella, refinanced near-term unsecured maturiti...
- Completed merger with Logan Ridge in July 2025 and rebranded to align with BC Partners credit platform, increasing scale and portfolio diversification.
- Tender offer bought ~558,000 shares for ~$7.6 million in December, accretive to NAV by $0.18 per share; board also authorized a new $10 million buyback program on March 4, 2026.
- Refinanced $108 million of unsecured notes maturing April 2026 by issuing $75 million 7.75% notes due October 2030 and $35 million 7.5% notes due October 2028, reducing near-term refinancing risk.
- +14 more takeaways
Drilling Tools International Q4 2025 Earnings Call - Record Free Cash Flow and Shrinking Leverage Amid Soft Rig Count
DTI closed 2025 by leaning into cash generation and capital discipline, producing record adjusted free cash flow while trimming net debt despite a 7% year-over-year rig count decline. Management highl...
- DTI reported consolidated 2025 revenue of $159.6 million, comprised of $129.6 million in rental revenues and $30.1 million in product sales.
- 2025 adjusted net income was $3.4 million, adjusted diluted EPS was $0.10, adjusted EBITDA was $39.3 million, and adjusted free cash flow was $19.2 million.
- Q4 2025 consolidated revenue was $38.5 million, with tool rental revenue of $30.4 million and product sales of $8.1 million.
- +12 more takeaways
Orion Properties Year-End 2025 Earnings Call - Strategic Review Underway, Portfolio Stabilized and Core FFO Poised to Grow
Orion opened a public strategic options review while arguing its recent operating moves have materially de-risked the company and set it up for Core FFO growth in 2026. Management pointed to heavy lea...
- Orion has launched a public strategic options review, the process is early, but management says it remains open to actionable proposals while pursuing its standalone plan.
- Leasing activity accelerated in 2025 with over 900,000 sq ft signed, on top of 1.1 million sq ft in 2024, and an additional 183,000 sq ft signed post-year-end.
- New leases in 2025 averaged nearly 10 years WALT, overall leasing activity averaged 7.5 years WALT, and the company says portfolio WALT is approaching 6 years.
- +12 more takeaways
Cohen & Company Q4 2025 Earnings Call - SPAC and CCM-led surge drives 246% revenue growth, but sponsor-share accounting clouds the headline
Cohen & Company closed 2025 with a blowout top line, driven almost entirely by its full service boutique, Cohen & Company Capital Markets, and heavy SPAC activity. Full year revenue jumped to $275.6 m...
- Full year 2025 revenue was $275.6 million, a 246% increase versus 2024, driven largely by Cohen & Company Capital Markets, CCM.
- CCM generated $184 million in 2025, a 370% increase from 2024, and accounted for 67% of total company revenue for the year.
- Q4 2025 investment banking and new issue revenue was $55 million, of which $50.8 million came from CCM and was primarily SPAC IPO and SPAC M&A related.
- +12 more takeaways
Imperial Petroleum Q4 and 2025 Earnings Call - Debt-free rapid fleet growth to ~26 ships, riding a tanker rate windfall as Middle East risk looms
Imperial Petroleum closed 2025 with a punchy quarter, using favorable tanker and dry bulk markets to convert rapid fleet expansion into cash and profits. Q4 revenue jumped to $51.1 million, up 95% yea...
- Fleet expansion executed fast and largely cash-funded, fleet on water now 20 vessels, expected to reach about 26 after six more deliveries in 2026.
- Q4 2025 revenues were $51.1 million, a 95% increase versus Q4 2024.
- Q4 net income was $15 million, roughly $11.1 million higher than the prior-year quarter; full-year 2025 net income was $50 million.
- +13 more takeaways
Hutchison China MediTech Limited 2025 Earnings Call - Cash Cushion and ATTC Push as Fusic Sales Climb
HCMT closed 2025 with healthy operational momentum and a clear pivot toward innovative ATTC (antibody targeted therapeutic conjugate) programs. FUSIC/FRUZAQLA posted strong global sales growth, China ...
- 2025 oncology revenue was $286 million, with FUSIC/FRUZAQLA global sales of $366 million, up 26% year over year.
- FUSIC/FRUZAQLA is now marketed in over 38 countries, with Japan and some EU markets driving acceleration; US sales face headwinds from federal Medicare changes.
- China oncology sales rebounded strongly in H2 2025, up about 21% year over year, driven largely by endometrial cancer uptake for the key product.
- +14 more takeaways
Cooper Companies Q1 FY2026 Earnings Call - Operational Beat and Guidance Raise, Japan Drag in Asia Pac
Cooper reported a clean operational quarter, beating on margins and cash flow while nudging full-year EPS and free cash flow guidance higher. Execution from last year’s reorganization, tighter OpEx an...
- Consolidated Q1 revenue $1.024 billion, up 6.2% year over year, organic growth 2.9%.
- CooperVision Q1 revenue $695 million, up 7.6% (3.3% organic). CooperSurgical Q1 revenue $329 million, up 3.3% (2.2% organic).
- Non-GAAP EPS $1.10, up 20% year over year. Gross margin 68.1%, operating income up 13.9% with a roughly 26.9% operating margin. OpEx improved to 41.2% of sales from 43.6% a year ago.
- +10 more takeaways
Guidewire Software Q2 Fiscal 2026 Earnings Call - AI urgency is pushing insurers to cloud, driving 22% ARR growth and longer contracts
Guidewire reported a strong Q2 fiscal 2026, with ARR up 22% year over year to $1.121 billion and fully ramped ARR reaching $1.42 billion. Management says generative AI is not a threat, it is an accele...
- ARR ended Q2 at $1.121 billion, up 22% year over year (21% constant currency).
- Fully ramped ARR finished Q2 at $1.42 billion, and has been growing faster than reported ARR for the past three years.
- Guidewire raised full-year ARR guidance to $1.229 billion - $1.237 billion, implying 18% - 19% growth year over year.
- +15 more takeaways